International Trade committee  It's not as clear-cut as that. When you mention the end of dual litigation, there are a number of fairly significant components to that equation that I tried to outline in my initial points. We have unique aspects in Canada. We have section 8 damages. Does ending dual litigation

International Trade committee  The first point I would make, and it's the point I opened with, is that we can have that discussion. If the government would like to discuss efficiencies and issues with respect to the current linkage regime, we're certainly open to that. The fundamental issue for us is that th

International Trade committee  There are some products...and I think you'll see recently in the field of oncology where the development time and the regulatory approval time are in some cases less than five years, but certainly two years is less than what is offered in Europe.

International Trade committee  It depends on what the basis for the exclusivity is. And we talk about it. I read Mr. Keon's testimony. It's not taking the 20-year term and adding two years. There is a practical amount of exclusivity that innovators enjoy in the market. That's in the neighbourhood of around 10

International Trade committee  Thank you, Russell. Thank you for the opportunity to speak to the committee today. Dual litigation, as a first point, was never raised with the innovative industry in the context of CETA, and we are deeply concerned about any changes that grant the industry a right of appeal a

International Trade committee  I think that's generally correct. Obviously, the devil will be in the details of how it's implemented, but if it follows the European supplemental protection certificate model, that's generally how it will work.